Sagong, Hye Yeon
Rosado-Lugo, Jesus D.
Bryan, Eric J.
Ferrer-González, Edgar
Wang, Yiling
Cao, Yanlu
Parhi, Ajit K.
Pilch, Daniel S.
LaVoie, Edmond J. https://orcid.org/0000-0001-9244-1249
Article History
Received: 4 July 2022
Accepted: 30 August 2022
First Online: 14 September 2022
Compliance with ethical standards
:
: The authors declare the following competing financial interest(s): EJLV and DSP are co-founders of TAXIS Pharmaceuticals, Inc. and AKPP is a shareholder and therefore have a financial interest in the company.